Information Provided By: 
Fly News Breaks for November 6, 2015
ENDP
Nov 6, 2015 | 07:51 EDT
UBS said the Street was clearly disappointed by the Endo deal with Auxilium but the firm feels its Xiaflex product should be a meaningful growth driver. The firm was surprised by the weakness in the shares and believes things are better than what the stock is showing. UBS reiterated its Buy rating and $100 price target on Endo shares.
News For ENDP From the Last 2 Days
There are no results for your query ENDP
